[Hemocomponent therapy of central involution chorioretinal dystrophy]
Related Experiment Video
Updated: Oct 12, 2026

Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report
Published on: February 12, 2018
Hemocomponent therapy was used in 181 patients (347 eyes) with central chorioretinal dystrophy. Activated autoplasma possessing a marked resorptive effect, consisting in resorption of hemorrhages and exudations on the fundus oculi, was used. Vision acuity improved in 75% of examined eyes by an average of 0.2 diopters.
Hemocomponent therapy was used in 181 patients (347 eyes) with central chorioretinal dystrophy. Activated autoplasma possessing a marked resorptive effect, consisting in resorption of hemorrhages and exudations on the fundus oculi, was used. Vision acuity improved in 75% of examined eyes by an average of 0.2 diopters.
Related Concept Videos
Angle Closure Glaucoma: Treatment
Continuous Renal Replacement Therapy
Diabetic Retinopathy

